This provider's $13.0M in total Medicare payments ranks in the 93th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2023 | $264.50 | $258.75 | 1.02x | $5.75 | $13.0M | 50.2K | 33 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 1.4K | $960.0K | $662.97 | 1.02x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 1.4K | $953.4K | $662.97 | 1.02x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 1.5K | $922.8K | $629.01 | 1.02x |
| 81185 | Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence | 1.1K | $912.3K | $829.34 | 1.02x |
| 81325 | Gene analysis (peripheral myelin protein 22), full sequence analysis | 1.1K | $831.1K | $754.19 | 1.02x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 991 | $582.7K | $588.00 | 1.02x |
| 81302 | Gene analysis (methyl cpg binding protein 2) full sequence analysis | 1.1K | $572.7K | $517.31 | 1.02x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 944 | $555.1K | $588.00 | 1.02x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 288 | $515.1K | $1.8K | 1.03x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 986 | $482.2K | $489.02 | 1.02x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 602 | $460.2K | $764.40 | 1.02x |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | 1.7K | $456.2K | $269.33 | 1.02x |
| 81364 | Gene analysis (hemoglobin, subunit beta) full sequence analysis | 1.1K | $353.1K | $318.09 | 1.02x |
| 81189 | Gene analysis (cystatin b) of full sequence | 1.1K | $298.1K | $269.33 | 1.03x |
| 81274 | Gene analysis (huntingtin) for characterization of alleles | 1.1K | $297.3K | $269.33 | 1.02x |
| 81286 | Gene analysis (frataxin) of full sequence | 1.1K | $285.0K | $269.33 | 1.02x |
| 81191 | Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis | 1.1K | $224.7K | $203.16 | 1.02x |
| 81192 | Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis | 1.1K | $224.7K | $203.16 | 1.02x |
| 81295 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 595 | $222.6K | $374.07 | 1.02x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 1.1K | $195.1K | $181.50 | 1.02x |
This provider submits charges 1.02 times higher than what Medicare actually pays.
A markup ratio of 1.02x means for every $100 Medicare pays, this provider initially charges $102. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Norristown, PA | $340.6M | ✓ Clear |
| Quest Diagnostics Of Pennsylvania, Inc. | Pittsburgh, PA | $130.4M | ⚠️ Flagged |
| Health Network Laboratories, Llc | Allentown, PA | $125.3M | ⚠️ Flagged |
| Sma Medical, Inc. | Feasterville, PA | $100.9M | ✓ Clear |
| Interpace Diagnostics Corporation | Pittsburgh, PA | $95.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data